ClickCease

Regulatory Affairs (Pharma/Biotech)

This niche is less exposed because it depends on navigating complex, evolving regulations, liaising with regulators, and preparing submissions. AI can support document preparation, compliance scanning, and data extraction, but the tacit, relationship-driven side of regulatory affairs remains human-led.

35

/100

Risk Breakdown

Hey I'm Rosie, a Venture Builder at Mayfly Ventures.
Let's jump on a call to explore big ideas together.

Button Text

Risk Summary

Regulatory Affairs (Pharma/Biotech) scores 35, a medium disruption risk. AI strengthens document scanning and preparation, while consultants remain indispensable for regulator engagement and contextual judgement. Significant opportunities remain to leverage AI for innovation and differentiation within this category.

Start your AI Journey

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Join us at one of our Industry Events

We put on events with industry leaders:

Next Event

AI for SMEs:

A collaborative workshop for SME business owners

7 Aug 10am - 12:45pm
Cremone Digital Hub
Button Text

Hey I'm Rosie, a Venture Builder at Mayfly Ventures.
Let's jump on a call to explore big ideas together.

Button Text